Rare diseases
Investigational molecules
Locations
Ul. Lubinowa 12/8, 52-210 Wroclaw, Poland
Planetmed Sp. z o.o. in Wroclaw, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Primary biliary cholangitis, Coeliac disease, and other specialisations. This site conducts important research.
At Planetmed Sp. z o.o. researchers are focusing on conditions of the gastrointestinal tract, aiming to test new therapies that can bring clinical remission and improve quality of life for patients.
The site has launched 26 trials with a team of four investigators, exploring innovative treatments and better diagnostic tools for these digestive disorders.
Studies at this centre evaluate novel agents designed to modulate autoimmune inflammation in diseases such as Crohn’s disease and ulcerative colitis.
Across 26 clinical trials, investigators are assessing the safety and effectiveness of emerging immunomodulators to achieve lasting disease control.
Research here delves into the underlying immune system mechanisms that drive chronic gut inflammation, seeking biomarkers and therapeutic targets.
The 26 ongoing studies involve comprehensive safety monitoring and efficacy assessments to translate immune insights into patient benefit.
Clinical trials currently enrolling participants at this site.
Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PolandTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
PolandStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
PolandStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
PolandStudy of Elafibranor for Adults with Primary Biliary Cholangitis
PolandStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
PolandStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
PolandA study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
PolandPhase 2b Study of ATH-063 in Adults with Biologic‑Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis
PolandStudy on BI 3032950 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Safety and Effectiveness of AZD7798 for Adults with Ileal Crohn's Disease and an Ileostomy
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
